ICG fluorescence imaging in colorectal surgery: a snapshot from the ICRAL study group.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
10 Apr 2021
Historique:
received: 08 12 2020
accepted: 24 03 2021
entrez: 11 4 2021
pubmed: 12 4 2021
medline: 14 4 2021
Statut: epublish

Résumé

Fluorescence-guided visualization is a recently proposed technology in colorectal surgery. Possible uses include evaluating perfusion, navigating lymph nodes and searching for hepatic metastases and peritoneal spread. Despite the absence of high-level evidence, this technique has gained considerable popularity among colorectal surgeons due to its significant reliability, safety, ease of use and relatively low cost. However, the actual use of this technique in daily clinical practice has not been reported to date. This survey was conducted on April 2020 among 44 centers dealing with colorectal diseases and participating in the Italian ColoRectal Anastomotic Leakage (iCral) study group. Surgeons were approximately equally divided based on geographical criteria from multiple Italian regions, with a large proportion based in public (89.1%) and nonacademic (75.7%) centers. They were invited to answer an online survey to snapshot their current behaviors regarding the use of fluorescence-guided visualization in colorectal surgery. Questions regarding technological availability, indications and techniques, personal approaches and feelings were collected in a 23-item questionnaire. Questionnaire replies were received from 37 institutions and partially answered by 8, as this latter group of centers do not implement fluorescence technology (21.6%). Out of the remaining 29 centers (78,4%), fluorescence is utilized in all laparoscopic colorectal resections by 72.4% of surgeons and only for selected cases by the remaining 27.6%, while 62.1% of respondents do not use fluorescence in open surgery (unless the perfusion is macroscopically uncertain with the naked eye, in which case 41.4% of them do). The survey also suggests that there is no agreement on dilution, dosing and timing, as many different practices are adopted based on personal judgment. Only approximately half of the surgeons reported a reduced leak rate with fluorescence perfusion assessment, but 65.5% of them strongly believe that this technique will become a minimum requirement for colorectal surgery in the future. The survey confirms that fluorescence is becoming a widely used technique in colorectal surgery. However, both the indications and methods still vary considerably; furthermore, the surgeons' perceptions of the results are insufficient to consider this technology essential. This survey emphasizes the need for further research to reach recommendations based on solid scientific evidence.

Sections du résumé

BACKGROUND BACKGROUND
Fluorescence-guided visualization is a recently proposed technology in colorectal surgery. Possible uses include evaluating perfusion, navigating lymph nodes and searching for hepatic metastases and peritoneal spread. Despite the absence of high-level evidence, this technique has gained considerable popularity among colorectal surgeons due to its significant reliability, safety, ease of use and relatively low cost. However, the actual use of this technique in daily clinical practice has not been reported to date.
METHODS METHODS
This survey was conducted on April 2020 among 44 centers dealing with colorectal diseases and participating in the Italian ColoRectal Anastomotic Leakage (iCral) study group. Surgeons were approximately equally divided based on geographical criteria from multiple Italian regions, with a large proportion based in public (89.1%) and nonacademic (75.7%) centers. They were invited to answer an online survey to snapshot their current behaviors regarding the use of fluorescence-guided visualization in colorectal surgery. Questions regarding technological availability, indications and techniques, personal approaches and feelings were collected in a 23-item questionnaire.
RESULTS RESULTS
Questionnaire replies were received from 37 institutions and partially answered by 8, as this latter group of centers do not implement fluorescence technology (21.6%). Out of the remaining 29 centers (78,4%), fluorescence is utilized in all laparoscopic colorectal resections by 72.4% of surgeons and only for selected cases by the remaining 27.6%, while 62.1% of respondents do not use fluorescence in open surgery (unless the perfusion is macroscopically uncertain with the naked eye, in which case 41.4% of them do). The survey also suggests that there is no agreement on dilution, dosing and timing, as many different practices are adopted based on personal judgment. Only approximately half of the surgeons reported a reduced leak rate with fluorescence perfusion assessment, but 65.5% of them strongly believe that this technique will become a minimum requirement for colorectal surgery in the future.
CONCLUSION CONCLUSIONS
The survey confirms that fluorescence is becoming a widely used technique in colorectal surgery. However, both the indications and methods still vary considerably; furthermore, the surgeons' perceptions of the results are insufficient to consider this technology essential. This survey emphasizes the need for further research to reach recommendations based on solid scientific evidence.

Identifiants

pubmed: 33838677
doi: 10.1186/s12893-021-01191-6
pii: 10.1186/s12893-021-01191-6
pmc: PMC8035779
doi:

Substances chimiques

Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

190

Références

Colorectal Dis. 2018 Aug;20(8):O226-O234
pubmed: 29751360
Langenbecks Arch Surg. 2016 Sep;401(6):767-75
pubmed: 26968863
J Appl Physiol. 1976 Apr;40(4):575-83
pubmed: 776922
Colorectal Dis. 2020 Sep;22(9):1147-1153
pubmed: 32189424
Int J Colorectal Dis. 2020 Mar;35(3):471-480
pubmed: 31907595
BMC Surg. 2020 Jul 17;20(1):158
pubmed: 32680492
Updates Surg. 2020 Sep;72(3):811-819
pubmed: 32399595
Surg Endosc. 2018 Mar;32(3):1586-1592
pubmed: 29273871
BJS Open. 2020 Jun;4(3):499-507
pubmed: 32134216
Surg Endosc. 2019 May;33(5):1640-1649
pubmed: 30203201
Surg Endosc. 2020 Dec;34(12):5223-5233
pubmed: 32696147
J Am Coll Surg. 2015 Jan;220(1):82-92.e1
pubmed: 25451666
Visc Med. 2020 Apr;36(2):80-87
pubmed: 32355664
Surg Technol Int. 2018 Nov 11;33:77-83
pubmed: 30029290
Colorectal Dis. 2015 Oct;17 Suppl 3:7-11
pubmed: 26394736
Updates Surg. 2020 Jun;72(2):249-257
pubmed: 32436016
Tech Coloproctol. 2019 Jul;23(7):649-663
pubmed: 31240416
Biochem Med. 1976 Feb;15(1):17-21
pubmed: 942422
Surg Endosc. 2020 Jan;34(1):53-60
pubmed: 30903276
Int J Colorectal Dis. 2020 Jun;35(6):1133-1139
pubmed: 32291508
Surg Endosc. 2019 Jan;33(1):126-134
pubmed: 29934870
Surg Endosc. 2020 Oct;34(10):4281-4290
pubmed: 32556696
World J Gastroenterol. 2018 Jul 21;24(27):2921-2930
pubmed: 30038461

Auteurs

Gian Luca Baiocchi (GL)

Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili, Brescia, Italy. gianluca.baiocchi@unibs.it.

Gianluca Guercioni (G)

General Surgery Unit, CG Mazzoni Hospital, Ascoli Piceno, Italy.

Nereo Vettoretto (N)

General Surgery Unit, ASST Spedali Civili, Montichiari, BS, Italy.

Stefano Scabini (S)

General & Oncologic Surgery Unit, National Cancer Center "San Martino", Genova, Italy.

Paolo Millo (P)

General Surgery Unit, Aosta Regional Hospital, Aosta, Italy.

Andrea Muratore (A)

General Surgery Unit, Agnelli Hospital, Pinerolo, TO, Italy.

Marco Clementi (M)

General Surgery Unit, University Hospital, L'Aquila, Italy.

Giuseppe Sica (G)

General Surgery Unit, Policlinico Tor Vergata University Hospital, Roma, Italy.

Paolo Delrio (P)

Colorectal Surgical Oncology Unit, IRCCS G. Pascale Foundation, Napoli, Italy.

Graziano Longo (G)

General Surgery Unit, Policlinico Casilino, Roma, Italy.

Gabriele Anania (G)

General Surgery Unit, University Hospital, Ferrara, Italy.

Vittoria Barbieri (V)

General Surgery Unit, Cardinale G. Panico Hospital, Tricase, LE, Italy.

Pietro Amodio (P)

General Surgery Unit, Belcolle Hospital, Viterbo, Italy.

Carlo Di Marco (C)

General Surgery Unit, Conegliano Hospital (TV) ULSS2 Marca Trevigiana, Conegliano, Italy.

Gianandrea Baldazzi (G)

General Surgery Unit, ASST Nord Hospital, Sesto San Giovanni, MI, Italy.

Gianluca Garulli (G)

General Surgery Unit, Infermi Hospital, Rimini, Italy.

Alberto Patriti (A)

General Surgery Unit, Marche Nord Hospital, Pesaro e Fano, PU, Italy.

Felice Pirozzi (F)

General Surgery Unit, ASL Napoli2 Hospital, Pozzuoli, NA, Italy.

Raffaele De Luca (R)

General Surgery Unit, IRCCS Istituto Giovanni Paolo II, Bari, Italy.

Stefano Mancini (S)

General & Oncologic Surgery Unit, San Filippo Neri Hospital, Roma, Italy.

Corrado Pedrazzani (C)

General Surgery Unit, University Hospital, Verona, Italy.

Matteo Scaramuzzi (M)

General Surgery Unit, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, FG, Italy.

Marco Scatizzi (M)

General Surgery Unit, Santa Maria Annunziata Hospital, Firenze, Italy.

Lucio Taglietti (L)

General Surgery Unit, ASST Valle Camonica, Esine, Italy.

Michele Motter (M)

General Surgery Unit 1, Santa Chiara Hospital, Trento, Italy.

Graziano Ceccarelli (G)

General Surgery Unit, San Giovanni Battista Hospital, Foligno, PG, Italy.

Mauro Totis (M)

General Surgery Unit, San Gerardo Hospital, Monza, Italy.

Andrea Gennai (A)

General Surgery Unit, Sant'Andrea Hospital, La Spezia, Italy.

Diletta Frazzini (D)

General Surgery Unit, Ospedale Civile Di Pescara, Pescara, Italy.

Gianluca Di Mauro (G)

General Surgery Unit, Ospedale Di Ragusa, Ragusa, Italy.

Gabriella Teresa Capolupo (GT)

Colorectal Surgery Unit, Policlinico Universitario Campus Bio Medico, Roma, Italy.

Francesco Crafa (F)

General & Oncologic Surgery Unit, San Giuseppe Moscati Hospital, Avellino, Italy.

Pierluigi Marini (P)

General Surgery Unit, San Camillo Hospital, Roma, Italy.

Giacomo Ruffo (G)

General Surgery Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.

Roberto Persiani (R)

Minimally Invasive Oncologic Surgery Unit, IRCCS Policlinico Gemelli Foundation, Roma, Italy.

Felice Borghi (F)

General Surgery Unit, Santa Croce E Carle Hospital, Cuneo, Italy.

Nicolò de Manzini (N)

General Surgery Unit, University Hospital, Trieste, Italy.

Marco Catarci (M)

General Surgery Unit, CG Mazzoni Hospital, Ascoli Piceno, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH